AIDS RESEARCH CORE

RCNH艾滋病研究合作的总体目标 是加强IRV/AIDS研究的基础结构， 协调药学院的跨学科合作 和药物科学，佛罗里达A&M大学。 学院拥有 表明致力于通过“卓越的 关心”，并在生产少数民族研究人员的最前沿， 生物医学科学 尽管取得了重大进展， 了解人类的分子特征 免疫缺陷病毒（MV）和抗FHV药物的作用机制， 药剂的功效仍然处于低端。 所以一间 积极开发新的抗ERV药物及其作用机制 通过协调的研究合作规划行动。 另一 这项活动的动力是采取措施， 参与调查的少数族裔人数持续不均衡 在艾滋病研究中。 艾滋病研究的困难在于 历史上的黑人学院和大学是由于缺乏 充足的资源、训练有素的调查人员和研究机构 治疗艾滋病 为了实现这一目标，ARC制定了以下措施 本申请的四个具体目标：（1）加强研究 合作活动;（2）增加少数民族研究人员（教师） （3）加强细胞培养和计算机辅助 分子模拟实验室;（4）支持FHV/AIDS研究 药物发现和药物/治疗领域的项目 评价 这项活动的成果是积极的 对大学研究界的影响; 少数民族艾滋病研究人员和他们的竞争力， 协作和共享资源;以及 公布将导致资金增加的结果 调查人员的机会。

The overall goal of the AIDS Research Collaboration (ARC) of RCNH is to strengthen the infi-astructure for IRV/AIDS research through coordinated interdisciplinary collaboration at the College of Pharmacy and Pharmaceutical Sciences, Florida A&M University. The College has demonstrated commitment to minority education through "excellence with caring", and is at the forefront in producing minority researchers in the biomedical sciences. Despite the significant progress made in understanding the molecular characteristics of the human immunodeficiency virus (MV) and action mechanism of anti-FHV agents, the efficacy of the agents remain at the low end. Therefore, an aggressive exploitation of new anti-ERV agents and their mechanism of action is planned through coordinated research collaboration. Another impetus for this activity is to take a step toward a remedy of the persistent disparity in the number of minority investigators involved in FflV/AIDS research. The difficulty in implanting AIDS research at historically black colleges and universities is due to the lack of adequate resources, trained investigators and research infiwtructure for AIDS. In fight of the goal, the ARC has developed the following four specific aims in this application: (1) enhance research collaboration activities; (2) increase minority investigators (faculty and graduate students); (3) augment cell culture and computer-based molecular modeling laboratories; and (4) support FHV/AIDS research projects in the area of drug discovery and phamiaceutical/therapeutic evaluation. The vqxrted outcomes of this activity are the positive impact on the university research community; an increased number of competent minority AIDS researchers and their competitiveness through collaboration and sharing resources; and high productivity in publishing results that will lead to an increase in funding opportunities for investigators.